Antimicrobial Peptidomimetics Prevent the Development of Resistance against Gentamicin and Ciprofloxacin in 𝑺𝒕𝒂𝒑𝒉𝒚𝒍𝒐𝒄𝒐𝒄𝒄𝒖𝒔 𝒂𝒏𝒅 𝑷𝒔𝒆𝒖𝒅𝒐𝒎𝒐𝒏𝒂𝒔 Bacteria